WEBSITECHANGES

Website Changes

---

04/15/2024

Ivy Brain Tumor Center Announces Promising Results of Phase 0/1 Glioblastoma Study at AACR Annual Meeting

---

04/15/2024

Upcoming Musella Foundation May Webinars!

---

04/15/2024

UCLA Brain Tumor Center to Host 24th Annual UCLA Brain Tumor Conference

---

04/15/2024

`The Brain Surgeon`s Take` podcast episode with Dr. Al Musella on the Promising Pathway Act

---

04/11/2024

Evaluation of the EMulate Therapeutics Voyager`s ultra-low radiofrequency energy in murine model of glioblastoma

---

04/08/2024

Real-world cost-effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China

---

04/05/2024

Sex differences in adverse events in Medicare individuals > 66 years of age post glioblastoma treatment

---

04/03/2024

Tumor Takedown Fundraiser: Cape Coral, FL May 4, 2024

---

04/01/2024

Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide

---

04/01/2024

Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma

---

03/30/2024

Low-Grade Glioma Webinar TOMORROW

---

03/29/2024

Prolonged use of certain hormone drugs linked to increased brain tumor risk

---

03/29/2024

Advocacy Alert for Washington Residents! Comment publicly to support Washington State HCA coverage of Tumor Treating Fields

---

03/28/2024

METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer

---

03/28/2024

First Participant Receives Sonodynamic Therapy for Glioblastoma in New Clinical Trial

---

03/25/2024

Oncovir Inc. is Pushing the Boundaries of Medical Innovation with Hiltonol

---

03/25/2024

Switch to generic formulation of temozolomide results in statistically significant increase in grade 3 and 4 bone marrow toxicity in glioma patients in the province of Alberta

---

03/25/2024

Bill would allow treatment for terminally ill before FDA approval

---

03/18/2024

REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma

---

03/18/2024

The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database

---

03/18/2024

Hoops For Hannah: , a March Madness bracket contest!

---

03/17/2024

Musella Foundation Copay Program now closed to new and renewal patients

---

03/14/2024

Early clinical trial results show `dramatic and rapid` regression of glioblastoma after next generation CAR-T therapy

---

03/14/2024

Gallium maltolate webinar added to website!

---

03/12/2024

Rod Norland`s book receives praise from brain tumor community

---